The primary purpose of this mentored award is to prepare the applicant for a career as an independent physician scientist. The applicant proposes to acquire additional skills in cell biology and molecular analysis in the context of a project that is directly relevant to his clinical specialty. The-long term goals are: 1) to investigate the mechanism(s) and define the relationship between tumor related inflammation and cancer associated cachexia; and 2) to develop safe and effective anti-inflammatory treatment strategies for patients with progressive malignancy using (nutritional) eicosapentaenoic acid, (EPA)) and/or (pharmacologic) selective cyclo-oxygenase-II (COX-II) inhibitor agents. Anorexia, weight loss and the catabolism of lean body mass define the clinical syndrome of cancer-associated cachexia. Preventing or delaying cachexia is a clinically significant goal, since improved outcome and survival for cancer patients has been consistently demonstrated to parallel the preservation of lean body mass. 1-4 Clinical and experimental evidence from our lab and others supports the use of EPA as an anti-inflammatory therapy. EPA is a w-3 fatty acid that may attenuate the production of pro-inflammatory cytokines, growth factors and inflammatory mediators, in response to inflammatory stimuli, however the mechanism(s) remain to be defined. Hypothesis: EPA alone or in combination with COX-II inhibitors attenuate the tumor-related inflammation of progressive malignancy. To test this hypothesis we will use the in vitro RAW 264-7 cell culture model and the well-established rodent model of progressive malignancy resulting in cancer-cachexia, the methyl-cholanthrene (MCA) fibrosarcoma, with the following specific aims.
AIM1 : To evaluate in vitro EPA and/or COX-II inhibition of macrophage TNF-alpha, IL-1beta, prostaglandin E2, COX-II enzyme production, NF-kB activity and apoptosis.
AIM 2 : To evaluate in vivo EPA and/or COX-II inhibition therapies of tumor-related TNF-alpha, IL-1beta, prostaglandin E2, COX-Il enzyme production, NF-kB activity, apoptosis and regulation of the ubiquitin proteasome proteolytic pathway in response to progressive non-metastasizing malignancy.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois at Chicago
Schools of Medicine
United States
Zip Code
Boutros, Cherif; Somasundar, Ponnandai; Razzak, Anthony et al. (2010) Omega-3 fatty acids: investigations from cytokine regulation to pancreatic cancer gene suppression. Arch Surg 145:515-20
Aldridge, Christopher; Razzak, Anthony; Babcock, Tricia A et al. (2008) Lipopolysaccharide-stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by an omega-3 fatty acid lipid emulsion. J Surg Res 149:296-302
Razzak, Anthony; Aldrich, Chris; Babcock, Tricia A et al. (2008) Attenuation of iNOS in an LPS-stimulated macrophage model by omega-3 fatty acids is independent of COX-2 derived PGE2. J Surg Res 145:244-50
Dekoj, Thomas; Lee, Sang; Desai, Sagun et al. (2007) G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model. J Surg Res 139:106-12
Sharif, Suhail; Broman, Michael; Babcock, Tricia et al. (2006) A priori dietary omega-3 lipid supplementation results in local pancreatic macrophage and pulmonary inflammatory response attenuation in a model of experimental acute edematous pancreatitis (AEP). JPEN J Parenter Enteral Nutr 30:271-6
Babcock, Tricia A; Dekoj, Thomas; Espat, N Joseph (2005) Experimental studies defining omega-3 fatty acid antiinflammatory mechanisms and abrogation of tumor-related syndromes. Nutr Clin Pract 20:62-74
Zgodzinski, Witold; Dekoj, Thomas; Espat, N Joseph (2005) Understanding clinical issues in postoperative nutrition after pancreaticoduodenectomy. Nutr Clin Pract 20:654-61
Jho, David H; Cole, Shawn M; Lee, Ellyn M et al. (2004) Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther 3:98-111
Babcock, Tricia A; Helton, W Scott; Anwar, Khandaker N et al. (2004) Synergistic anti-inflammatory activity of omega-3 lipid and rofecoxib pretreatment on macrophage proinflammatory cytokine production occurs via divergent NF-kappaB activation. JPEN J Parenter Enteral Nutr 28:232-9; discussion 239-40
Breen, Heather B; Espat, N Joseph (2004) The ubiquitin-proteasome proteolysis pathway: potential target for disease intervention. JPEN J Parenter Enteral Nutr 28:272-7

Showing the most recent 10 out of 12 publications